Taban, H.; Erman, M.; Guven, D.C.; Aktas, B.Y.; Yilmaz, F.; Yaşar, S.; Yildirim, H.C.; Aslan, F.; Aksoy, S.
Prognostic Nutritional Index and a Blood-Based Prognostic Tool in Prostate Cancer Treated with Abiraterone, Enzalutamide or Cabazitaxel. Medicina 2025, 61, 1105.
https://doi.org/10.3390/medicina61061105
AMA Style
Taban H, Erman M, Guven DC, Aktas BY, Yilmaz F, Yaşar S, Yildirim HC, Aslan F, Aksoy S.
Prognostic Nutritional Index and a Blood-Based Prognostic Tool in Prostate Cancer Treated with Abiraterone, Enzalutamide or Cabazitaxel. Medicina. 2025; 61(6):1105.
https://doi.org/10.3390/medicina61061105
Chicago/Turabian Style
Taban, Hakan, Mustafa Erman, Deniz Can Guven, Burak Yasin Aktas, Feride Yilmaz, Serkan Yaşar, Hasan Cagri Yildirim, Ferit Aslan, and Sercan Aksoy.
2025. "Prognostic Nutritional Index and a Blood-Based Prognostic Tool in Prostate Cancer Treated with Abiraterone, Enzalutamide or Cabazitaxel" Medicina 61, no. 6: 1105.
https://doi.org/10.3390/medicina61061105
APA Style
Taban, H., Erman, M., Guven, D. C., Aktas, B. Y., Yilmaz, F., Yaşar, S., Yildirim, H. C., Aslan, F., & Aksoy, S.
(2025). Prognostic Nutritional Index and a Blood-Based Prognostic Tool in Prostate Cancer Treated with Abiraterone, Enzalutamide or Cabazitaxel. Medicina, 61(6), 1105.
https://doi.org/10.3390/medicina61061105